Bowel Dysfunction 3 Years After Anterior Resection a in a Swedish National Cohort
1 other identifier
observational
1,200
1 country
1
Brief Summary
The primary objectives are to evaluate the prevalence of LARS and Quality of Life in rectal cancer patients 3 years after anterior resection, to investigate if anastomotic technique is a risk factor for major LARS and to study the prevalence of colostomy 3 years after anterior resection and evaluate stoma function according to the stoma scale in EORTC QLQ-CR29.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 15, 2018
CompletedFirst Submitted
Initial submission to the registry
September 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2020
CompletedFirst Posted
Study publicly available on registry
October 19, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 15, 2020
CompletedFebruary 18, 2021
February 1, 2021
2.6 years
September 15, 2020
February 17, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Low Anterior Resection Syndrome score ( LARS Score)
Prevalence of low anterior resection syndrome (LARS) 3 years after low anterior resection for rectal cancer, assessed by the validated instrument LARS score consisting of 5 questions with a total score of between 4 and 42. .0-20 corresponds to no LARS, 21-29 to minor LARS and 30-42 to major LARS.
3 years
QoL
Quality of life measured by the validated EORTC (European Organisation for Research and Treatment of Cancer) questionnaires QLQ 30 (Quality of life questionnaire 30) consisting of 30 questions and CR 29 (colirecti 29), a specific questionnaire assessing quality of life in colorectal cancer patients, consisting of 29 questions. Both QLQ 30 and CR 29 include symptom scales and functional scales from 0-100 with lower scores on symptom scales indicating better quality of life and higher scores on functional scales indicating better quality of life.
3 years
Secondary Outcomes (1)
Correlation LARS score QoL
3 years
Eligibility Criteria
All patients with rectal cancer that have undergone anterior resection for rectal cancer between Q1 2015 and Q4 2017 in Sweden
You may qualify if:
- Clinical diagnosis of rectal cancer in Sweden
- Operated on with anterior resection between Q1 2015 and Q4 2017 in Sweden, with or without defunctioning stoma
You may not qualify if:
- Age \<18 years
- Dementia,
- Unable to understand Swedish language
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Region Skanelead
Study Sites (1)
Skane university hospital
Malmo, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marie-Louise Lydrup, Assoc prof
Dept of surgery, Skåne university hospital, Malmö, Sweden
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 15, 2020
First Posted
October 19, 2020
Study Start
February 15, 2018
Primary Completion
September 15, 2020
Study Completion
November 15, 2020
Last Updated
February 18, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share